Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 895-902

  Buemi, Michele ^a   Caccamo, Chiara ^a   Floccari, Fulvio ^a   Coppolino, Guiseppe ^a   Tripodo, Donatella ^a   Giacobbe, Maria Stella ^a   Senatore, Massimino ^a   Aloisi, Carmela ^a   Ruello, Antonella ^a   Sturiale, Alessio ^a   Ientile, Riccardo ^a   Crisafulli, Giuseppe ^a   Coppolino, Salvatore ^a   Villari, Antonino ^a   Frisina, Nicola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Brain; Complications; Hemodialysis; Hormones; Personality; Quality of life

Indexed keywords

DOPAMINE; NORADRENALIN; SEROTONIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; BIOLOGICAL MODEL; CLUSTER ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLOTHYMIA; DOPAMINERGIC SYSTEM; EMOTIONALITY; FEMALE; GENETIC VARIABILITY; HEALTH STATUS; HEALTH SURVEY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MENTAL HEALTH; MULTIPLE REGRESSION; NEUROBIOLOGY; NORADRENERGIC SYSTEM; PATIENT ATTITUDE; PERSONALITY; PHYSICAL CAPACITY; PSYCHOBIOLOGY; QUALITY OF LIFE; REWARD; SCORING SYSTEM; SELF EVALUATION; SEROTONINERGIC SYSTEM; SOCIAL STATUS; STATISTICAL ANALYSIS; STUDENT T TEST; SYMPTOM; BLOOD; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RENAL REPLACEMENT THERAPY;

DOPAMINE; FEMALE; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PERSONALITY; QUALITY OF LIFE; RENAL DIALYSIS; SEROTONIN;

EID: 1642487195     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Constitution of the World Health Organization. In World Health Organization. Handbook of basic documents 5th edn. Geneva Palais des Nations 1952; 3: 20.
2. Kopple JD, Zhu X, Lew NL, Lowerie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999; 56: 1136-48.
3. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using Short Form 36: Comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2000; 35: 293-300.
4. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF-36 quality of life measures and nutrition, hospitalisation, and mortality in hemodialysis. J Am Soc Nephrol 2001; 12: 2797-806.
5. Curtin RB, Lowrie EG, De Oreo PB. Self-reported functional status: An important predictor of health outcomes among end-stage renal disease, patients. Adv Ren Replace Ther 1999; 6: 133-40.
6. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
7. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
8. Garray AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 1993, 306: 1437-40.
9. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986; 4: 167-226.
10. Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry 2000; 5: 96-100.
11. Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Nanko S, Akiyoshi J. Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol Psychiatry 1999; 45: 368-70.
12. Kumakiri C, Kodama K, Shimizu E, Yamanouchi N, Okada S, Noda S, Okamoto H, Sato T, Shirasawa H. Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neurosci Lett 1999; 263: 205-7.
13. Chatterjee S, Sunitha TA, Velajaudhan A, Khanna S. An investigation into the psychobiology of social phobia: personality domains and serotoninergic function. Acta Psychiatr Res 1997; 30: 21-7.
14. Curtin F, Walker JP, Peyrin L, Soulier V, Badan M, Schulz P. Reward dependence is positively related to urinary monoamines in normal men. Biol Psychiatry 1997, 42: 275-81.
15. Stellar JR, Stellar E. The neurobiology of motivation and reward. New York, Springer-Verlag NY Inc 1985.
16. Routtenberg A. The reward system of the brain. Sci Am 1978; 239: 154-64.
17. Meier PC, Zund RE. A statistical method in analytical chemistry. Wiley-Interscience Publ, John Wiley & Sons, Inc; 197-9.
18. Evans RW, Manninen DL, Garrison LP, Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-9.
19. Kahn IH, Garratt AM, Kumar A, Cody DJ, Catto GRD, Edward N, Macleod AM. Patient's perceptions of health on renal replacement therapy: evaluation using a new instrument. Nephrol Dial Transplant 1995; 10: 684-9.
20. Meyer KB, Espindle DM, De Giacomo JM, Jenuleson CS, Kurtin PS, Ross Davies A. Monitoring dialysis patients' health status. Am J Kidney Dis 1994; 24: 267-79.
21. Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT, and the NECOSAD study group. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis 1997; 29: 584-92.
22. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-63.
23. Grimm G, Stockenhuber F, Schneeweiss B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 1990; 38: 480-6.
24. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. The Cooperative Multicenter EPO Clinical Trial Group. JAMA 1990; 263: 825-30.
25. Paganini EP. FACP in search of an optimal hematocrit level in dialysis patients: Rehabilitation and quality of life implications. Am J Kidney Dis 1994; 24 (suppl 1): S10-6.
26. Moreno F, Aracil FJ, Perez R. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Am J Kidney Dis 1996; 27: 548-56.
27. Bond AJ. Neurotransmitters, temperament and social functioning. Eur Neuropsychopharmacol 2001; 11: 261-74.
28. Benjamin J, Li L, Patterson. C, Greenberg B, Murphy D, Hamer D. Population and familial association between the D4 dopamine receptor and measures of Novelty Seeking. Nat Genet 1996; 12: 81-4.
29. Svrakic DM, Draganic S, Hill K, Bayon C, Przybeck TR, Cloninger CR. Temperament, character and personality disorders: etiologic, diagnostic, treatment issues. Acta Psychiatr Scand 2002; 106: 189-95.
30. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders 4th edn. Washington DC: American Psychiatric Association 1994.